Renal Denervation Using the Vessix Renal Denervation System for the Treatment of Hypertension (REDUCE HTN:REINFORCE)
Completed · Not applicable
Conditions studied: Hypertension
In brief
The REDUCE HTN: REINFORCE study is being conducted to determine whether the Vessix Reduce™ Catheter and Vessix™ Generator for the treatment of uncontrolled hypertension (off-treatment office systolic blood pressure ≥150 mmHg and ≤180 mmHg) shows acceptable performance at 8 weeks when compared to a masked procedure (renal angiogram).
Key facts
- Study ID
- NCT02392351
- Run by
- Boston Scientific Corporation
- People needed
- 51
- Starts
- 2015-04-01
- Expected to finish
- 2019-08-02
- Last updated by the study team
- 2021-02-11
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age ≥18 and ≤75 years
- OSBP ≥150 mmHg and ≤180 mmHg based on an average of 3 office-based blood pressure measurements
- Average 24-hour ASBP ≥135 mmHg and ≤170 mmHg
- For each kidney, a main renal artery, with or without accessory renal arteries, with diameter ≥3.0 mm and ≤7.0 mm and length ≥20.0 mm
- Agrees to have all study procedures performed, and is competent and willing to provide written, informed consent
You may not qualify if…
- Stenosis >30% or renal artery aneurysm in either renal artery
- Fibromuscular dysplasia (FMD)
- Known causes of secondary HTN
- Type 1 diabetes mellitus
- eGFR <40 mL/min/1.73m2
- Known ejection fraction of <30% or heart failure that required hospitalization in the previous 6 months
- Severe valvular heart disease
- ≥1 episode(s) of orthostatic hypotension not related to medication changes (reduction of SBP of ≥20 mmHg or DBP of ≥10 mmHg within three minutes of standing) coupled with symptoms within the past year or during screening
Where it is running
- Cardiology, PC — Birmingham, Alabama, United States
- Cedars - Sinai Medical Center — Los Angeles, California, United States
- Mount Sinai Medical Center — Miami Beach, Florida, United States
- Cardiovascular Institute of the South — Houma, Louisiana, United States
- University of Maryland — Baltimore, Maryland, United States
- Tufts Medical Center — Boston, Massachusetts, United States
- Columbia University Medical Center — New York, New York, United States
- Albert Einstein Medical Center — Philadelphia, Pennsylvania, United States
- Wellmont CVA Heart Institute — Kingsport, Tennessee, United States
- Dallas Medical Center — Dallas, Texas, United States
- Cardiovascular Research Institute of Dallas — Dallas, Texas, United States
- Aspirus Heart and Vascular Institute — Wausau, Wisconsin, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.